Simba Gill - Apr 15, 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Simba Gill
Stock symbol
SER
Transactions as of
Apr 15, 2024
Transactions value $
$0
Form type
4
Date filed
4/17/2024, 06:01 PM
Previous filing
Apr 17, 2024
Next filing
Jun 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +295K $0.00 295K Apr 15, 2024 Common Stock 295K $11.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 25% of the underlying shares on October 15, 2024 and thereafter in substantially equal monthly installments such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.